The t(16;21)(p11;q22) translocation is a recurrent chromosomal abnormality found in several types of myeloid leukemia. We have previously demonstrated that the breakpoints of this translocation are clustered in a specific intron of the ERG gene on chromosome 21, which has recently been reported to be involved in Ewing's sarcoma. We show here that the TLS/FUS gene on chromosome 16 is fused with the ERG gene to produce the TLS/FUS-ERG chimeric transcript by this translocation. The TLS/FUS gene has been identified as a translocated gene in myxoid liposarcoma by the t(12;16)(q13;p11) translocation and encodes an RNA-binding protein that is highly homologous to the product of the EWS gene involved in Ewing's sarcoma. Thus, the TLS/FUS-ERG gene fusion in t(16;21) leukemia is predicted to produce a protein that is very similar to the EWS-ERG chimeric protein responsible for Ewing's sarcoma.

1

This work was supported in part by a Grant-in-Aid for Comprehensive 10-year Strategy for Cancer Control, a Research Grant on Aging and Health from the Ministry of Health and Welfare; Grants-in-Aid for Creative Basic Research (Human Genome Program), Cancer Research, and Scientific Research on Priority Areas from the Ministry of Education, Science, and Culture; and a grant from the Special Coordination Funds for Promotion of Science and Technology from the Science and Technology Agency of Japan.

This content is only available via PDF.